Tiziana Life Sciences Ltd.
Last updated September 27, 2026
Organization details
- Legal name
- Tiziana Life Sciences Ltd.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Bermuda
- Headquarters city
- London, England
- Headquarters country
- United Kingdom
- Fiscal year end
- December
- Ticker symbol
- TLSA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001723069
Board of directors
-
Gabriele M. Cerrone · DirectorSince 2026
-
Ivor Elrifi · Director · CHIEF EXECUTIVE OFFICERSince 2026
Chief executives
Ivor Elrifi
· CHIEF EXECUTIVE OFFICER
Since March 2026
Board connections
1 of this board's directors also sit on 1 other board.
- via Gabriele M. Cerrone
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $985,909
- 3 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 15, 2026 | Ivor Elrifi Officer (Chief Executive Officer) | Option exercise | +1,050,000 | — | — |
| Aug 5, 2026 | Ivor Elrifi Officer (Chief Executive Officer) | Open-market purchase | +237,616 | $1.00 | $237,616 |
| Aug 4, 2026 | Ivor Elrifi Officer (Chief Executive Officer) | Open-market purchase | +83,807 | $0.97 | $81,293 |
| Aug 3, 2026 | Ivor Elrifi Officer (Chief Executive Officer) | Open-market purchase | +667,000 | $1.00 | $667,000 |
| Jul 21, 2026 | Gabriele M. Cerrone Director, 10% owner | Grant or award | +42,357 | $0.99 | $41,933 |
| Jun 12, 2026 | Gabriele M. Cerrone Director, 10% owner | Grant or award | +15,000 | $1.11 | $16,650 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.